Fecal microbiomes of laboratory beagles receiving antiparasitic formulations in an experimental setting

Abstract

Here we describe the fecal microbiome of laboratory beagles in a non-invasive and humane experiment designed to contrast in vivo versus invitro bioequivalence in response to antiparasitic drug administration. The experiment provided a unique opportunity to describe the fecal microbiota of dogs in an experimental setting prior to their adoption. These data are contributed as a resource for the scientific community by the Center for Veterinary Medicine (CVM) of the U.S. Food and Drug Administration (FDA).